특허 및 논문

Intellectual Property (cont.)

48 Kim, T. H., Lee, S. -W.(2023) Generation of hepatitis C virus–resistant liver cells by genome editing–mediated stable expression of RNA aptamer. Mol Ther Methods Clin Dev. 2023, 31:101151.
47 Kim, J. H., Lee, C. H., Lee, S. -W.(2023) Adenovirus VA RNAs impair maturation of primary microRNA. J Gene Med . 2023, 25:e3564.
46 Lee, K. H., Song, J. H., Kim, S. C., Han, S. R., Lee, S. -W. (2023) Real-Time Monitoring Strategies for Optimization of In Vitro Transcription and Quality Control of RNA Front. Mol. Biosci. 2023, 10: 1229246
45 Lee, K. H., Kim, S. C., Song, J. H., Han, S. R., Kim, J. H., and Lee, S. -W. (2023) Efficient circular RNA engineering by end-to-end self-targeting and splicing reaction using Tetrahymena group I intron ribozyme Mol. Ther. Nucleic Acids 2023, 33, 587-598
44 Lee, K. H., Kim, S. C., and Lee, S. -W. (2022) Pros and Cons of In Vitro Methods for Circular RNA Preparation Int. J. Mol. Sci.2022, 23, 13247
43 Kim, T. H., and Lee, S.-W. (2022) Therapeutic application of genome editing technologies in viral diseases. International Journal of Molecular Sciences 23(10): 45399.
42 Kim, T. H., and Lee, S.-W. (2021) Aptamers for anti-viral therapeutics and diagnostics. International Journal of Molecular Sciences 22(8): 4168.
41 Han, S. R., Lee, C. H., Im, J. Y., Kim, J. H., Kim, J. H., Kim, S. J., Cho, Y. W., Kim, E., Kim, Y., Ryu, J.-H., Ju, M. H., Jeong, J. S., and Lee, S.-W. (2021) Targeted suicide gene therapy for liver cancer based on ribozyme-mediated RNA replacement throu
40 Seo, M.-J., Park, J. H., Lee, K. C., Lee, Y. J., Lee, T. S., Choi, T. H., Lee, S.-W., Kim, K. I., and Kang, J. H. (2020) Small animal PET imaging of hTERT RNA-targeted HSV1-tk gene expression with trans-splicing ribozyme. Cancer Biotherapy and Radiopharma
39 Lee, C. H., Han, S. R., and Lee, S.-W. (2018) Group I intron-based therapeutics through trans-splicing reaction. Progress in Molecular Biology and Translational Science 159: 79-100.